These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4049190)

  • 1. [Netilmicin in comparison with tobramycin in the therapy of severe infections in nephropathic patients].
    Chiarini C; Marchesi E; Rigotti A; Spongano M; Galleri C
    Minerva Urol Nefrol; 1985; 37(1):29-33. PubMed ID: 4049190
    [No Abstract]   [Full Text] [Related]  

  • 2. Variability in pharmacokinetic values for gentamicin, tobramycin, and netilmicin in patients with renal insufficiency.
    Matzke GR; Millikin SP; Kovarik JM
    Clin Pharm; 1989 Nov; 8(11):800-6. PubMed ID: 2805631
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of netilmicin and tobramycin therapy in patients with renal impairment.
    Gorse GJ; Bernstein JM; Cronin RE; Etzell PS
    Scand J Infect Dis; 1992; 24(4):503-14. PubMed ID: 1411317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative clinical efficacy and safety of netilmicin and tobramycin in children with serious gram-negative infections.
    Weippl G
    Clin Ther; 1983; 5(4):342-7. PubMed ID: 6347380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Netilmicin treatment of complicated urinary tract infections.
    Madsen PO; Baumueller A; Frimodt-Møller N; Hoyme U; Lau C; Maigaard S; Nielsen OS; Welling PG
    Scand J Infect Dis Suppl; 1980; Suppl 23():128-31. PubMed ID: 6937956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Netilmicin and tobramycin: comparative evaluation of pharmacokinetics, nephrotoxicity, and therapeutic efficacy in animal studies (author's transl)].
    Marre R; Abraham M; Freiesleben H; Sack K
    Arzneimittelforschung; 1979; 29(6):940-5. PubMed ID: 582788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Netilmicin: chemical development and overview of clinical research.
    Herting RL; Lane AZ; Lorber RR; Wright JJ
    Scand J Infect Dis Suppl; 1980; Suppl 23():20-9. PubMed ID: 7010547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin.
    Lerner AM; Reyes MP; Cone LA; Blair DC; Jansen W; Wright GE; Lorber RR
    Lancet; 1983 May; 1(8334):1123-6. PubMed ID: 6133153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Netilmicin in the treatment of severe or complicated urinary tract infections.
    Peddie BA; Bailey RR; Blake E; Summerfield MJ
    N Z Med J; 1980 May; 91(660):378-81. PubMed ID: 6931321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobramycin in the treatment of severe and complicated urinary tract infections.
    Bailey RR; Peddie B
    N Z Med J; 1976 Jul; 84(567):1-3. PubMed ID: 823477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Netilmicin therapy of serious renal and urinary tract infections in patients with normal and impaired renal function.
    Denneberg T; Haeger K; Juhlin I
    Scand J Infect Dis Suppl; 1980; Suppl 23():135-40. PubMed ID: 6937958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective, randomized comparison of the efficacy and safety of netilmicin-clindamycin and tobramycin-clindamycin in the treatment of serious systemic infections.
    Kahalley S; Chandler J; Hawkins J; Norris G; Waugespack R; Snow RM
    Clin Ther; 1985; 7(4):497-506. PubMed ID: 4016829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Netilmicin in the treatment of gram-negative bacillary infections.
    Messihi J; Smith LG; Najjar S
    J Med Soc N J; 1983 Mar; 80(3):193-6. PubMed ID: 6575181
    [No Abstract]   [Full Text] [Related]  

  • 14. A survey of prospective, controlled clinical trials of gentamicin, tobramycin, amikacin, and netilmicin.
    Cone LA
    Clin Ther; 1982; 5(2):155-62. PubMed ID: 6760967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled clinical trial on etimicin, a new aminoglycoside antibiotic, versus netilmicin in the treatment of bacterial infections.
    Zhao C; Li J; Hou J; Guo M; Zhang Y; Chen Y
    Chin Med J (Engl); 2000 Nov; 113(11):1026-30. PubMed ID: 11776118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of netilmicin in the treatment of infections of the urinary tract].
    Avogadro A; Mauri A; Vaccari R; Cainarca M; Secreto G; Franch L; Franchino L
    Clin Ter; 1986 Jun; 117(5):403-7. PubMed ID: 3742963
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of netilmicin therapy in serious infections.
    Jahre JA; Fu KP; Neu HC
    Am J Med; 1979 Jan; 66(1):67-73. PubMed ID: 420253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy and toxicity of netilmicin in the treatment of gram-negative infections.
    Buckwold FJ; Ronald AR; Lank B; Thompson L; Fox L; Harding GK
    Can Med Assoc J; 1979 Jan; 120(2):161-7. PubMed ID: 761144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Netilmicin therapy of gentamicin-sensitive and resistant gram-negative infections.
    Pollock AA; Stein AJ; Simberkoff MS; Rahal JJ
    Am J Med Sci; 1981; 282(1):2-11. PubMed ID: 6973928
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of aminosides in the burn patient].
    Galizia JP; Besse MD; Goldstein P; Marson JC; Crépy A; Pellerin P
    Cah Anesthesiol; 1986 Oct; 34(6):495-9. PubMed ID: 3801960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.